DOI: http://dx.doi.org/10.18203/2320-1770.ijrcog20184955

Comparison between sublingual 600 and 800 microgram misoprostol after mifepristone for MTP up to 9 weeks gestation

Srishti Thakur, Charu Pratap

Abstract


Background: The objective of the present study was to compare the efficacy between sublingual 600 and 800 microgram Misoprostol after administration of Mifepristone up to 9 weeks gestation, to compare the incidence of side effects between the two doses. To compare the acceptability between the two doses.

Methods: This study is a single-center, randomized study. The study is conducted at Fortis Escorts Hospital and Research Centre, Faridabad, during period of May 2014 to June 2015. 160 Pregnant women with singleton pregnancy up to 9 weeks gestation, visiting OPD of Obstetrics and Gynaecology, who wanted MTP by drug, after taking care of inclusion and exclusion criteria. An informed consent was taken from all the women.

Results: In terms of efficacy, both the groups were comparable (p value 0.509). Blood loss was comparable in both the groups (p value 0.147). In terms of side effects, itching and rashes (p value 0.004) and abdominal cramps (p value 0.001) was found to be more in women taking 800ug Misoprostol. Also, need for analgesia (p value 0.001) was found to be more in women taking 800ug Misoprostol.

Conclusions: Sublingual Misoprostol is comfortable and easier administration when compared to other routes and it has potential to be developed as a self-administered regimen. 600ug Sublingual Misoprostol is as efficacious as 800ug sublingual Misoprostol with significantly lesser side effects up to 7 weeks of gestation.


Keywords


Mifepristone, Misoprostol, Sublingual

Full Text:

PDF

References


WHO Reproductive Health Library commentary. Evidence summary. last revised:3 September 2004

Rodger MW, Baird DT. Induction of therapeutic abortion in early pregnancy with Mifepristone in combination with prostaglandin. Lancet. 1987 Dec 19;2(8573):1415-8.

RCOG.Care of Women Requesting Induced Abortion: Evidence-based clinical guideline number 7 ,2004.

Bygdeman M, Swahn ML, Gemzell-Danielsson K, Svalander P. Mode of action of RU 486. Ann Med. 1993;25(1):61-4.

Spitz IM, Shoupe D, Sitruk- Ware R, Mishell DR Jr. Response to the antiprogestegen RU 486 (Mifepristone) during early pregnancy and the menstrual cycle in women.J Reprod Fertil Suppl. 1989;37:253-60.

Heikinheimo O, Ylikorkala O, Lahteenmaki P. Antiprogesterone Ru 486- a drµg for non-surgical abortion. Ann Med. 1990;22(2):75-84.

Heikinheimo O. Antiprogesterone steroid RU 486. Pharmacokinetics and receptor binding in humans. Acta Obstet Gynecol Scand. 1990;69(4):357-8.

Tang OS, Schweer H, Seyberth HW, Lee SW, Ho PC. Pharmacokinetics of different routes of administration of misoprostol. Hum Reprod 2002;17(2):332-6

Dahiya K, Mann S, Nanda S. Randomised trial of oral versus sublingual misoprostol 24 hour after mifepristone for medical abortion. Arch Gynaecol and Obstet. 2011;284(1):59-63.

AA S, VS R. Randomized Control Study of Oral Versus Vaginal and Sublingual Misoprostol with Mifepristone for First-Trimester MTP. Indian J Clinic Prac. 2013;24(7).

Shuchita M, Shveta K, Batya E, Suresh U. Simplifying medical abortion: home administration of misoprostol. J obstat Gynecol India. 2008;58(5):410-6.

Shetty J, Shanmugapriya T, Kamath A. Medical abortion by mifepristone with sublingual vs vaginal misoprostol: A randomised comparative trial. Health and Population: Perspect Iss. 2008;31(4):221-8.

Nusrat Shah. Sublingual versus vaginal misoprostol in the management of missed miscarriage.J Pak Med Assoc. 2010;60(2):113.

Mahler K. Early medical abortion regimens using different dosages of mifepristone are equally successful. Brit J Obstet Gynaecol. 2000;107(4):524-30.

Grossman D. Evidence summary”, Reproductive Health Library Commentary Evidence summary. WHO

Tang OS, Chan CC, Ng EH, Lee SW, Ho PC. A prospective, randomised, placebo-controlled trial on the use of Mifepristone with sublingual or vaginal misoprostol for medical abortions less than 9 week gestation. Hum Reprod. 2003;18(11):2315-8.

Hamoda H, Ashok PW, Pow J, Flett GM, Templeton A. A pilot study of mifepristone in combination with sublingual or vaginal misoprostol for medical termination of pregnancy up to 63 days gestation. Contracep. 2003;68(5):335-8.

Helena Von Hertzen et al,” Comparision of two doses and the two routes of administration of Misoprostol after pretreatment with Mifepristone for early pregnancy termination”, Reproduct Health 2008;5(1):2.

Jalil S. Sublingual Misoprostol in the management of first trimester miscarriage. Pak J Surg. 2010;26(2):169-73

Kulier R, Kapp N, Gülmezoglu AM, Hofmeyr GJ, Cheng L, Campana A. Medical methods for first trimester abortion. The Cochrane Library. 2011 Nov.

Tang OS, Xu J, Cheng L, Lee SWH, Ho PC. Pilot study on the use of sublingual misoprostol with mifepristone in termination of first trimester pregnancy up to 9 weeks gestation.Hum. Reprod.2002;17(7):1738-40.